Background: Ganoderma lucidum is a medicinal mushroom exhibiting numerous health 25 benefits primarily based on strong immunostimulatory effects. The aim of the study was 26 to investigate if there were differences in effects of extracts of commercially (GC) and 27 alternatively (wheat straw) (GA) cultivated G. lucidum basidiocarps on properties of 28 peritoneal macrophages (PM) and monocyte-derived dendritic cells (MoDCs). 29 Methods: Differences in immunomodulatory effects of GC/GA extracts were studied. 30 Viability of treated PMs, their adhesive and phagocytic capability and capacity to produce 31 reactive oxigen species (ROS) and NO was tested. Immature MoDCs generated from 32 human monocytes were treated with poly I:C (10.0 µg/ml) and loxoribine (34.0 µg/ml), a 33 selective TLR3 and TLR7 agonists, respectively, and with/without GC/GA extract (100.0 34 µg/ml). The effect of each combination on phenotypic properties, cytokines production by 35 MoDCs, and their proliferation and Th polarizing capacity was studied. 36 Results: GA extract stronger stimulated metabolic and phagocytic activity of PMs, their 37 adhesion capability and ability to produce ROS and NO compared to GC. Both tested 38 extracts significantly increased allostimulatory and Th1 polarization capacity of 39 simultaneous TLR3 and TLR7-activated MoDCs, but GA extract was more effective. 40 Discussion: The extract of alternatively cultivated G. lucidum basidiocarps increased 41 production of ROS and NO by TLR4 stimulated PMs and up-regulated production of 42 certain cytokines as well as allostimulatory and Th1 polarization capacity of MoDCs. GA 43 extract could be a potent immunostimulatory agent for activation of MoDCs with 44 simultaneous engagement of TLRs that seems to be a promising strategy for preparation 45 of DC-based anti-tumor vaccines. 46 47
Introduction

52
Ganoderma lucidum (Curtis) P. Karst., known as Reishi, is a popular medicinal 53 mushroom used in traditional medicine for the prevention and treatment of various 54 pathological conditions. Today, there is evidence that bioactive constituents of this 55 species are responsible for numerous health benefits due to strong immunomodulatory, 56 antitumor, antioxidative, anti-inflammatory, antimicrobial and many other activities (Lin Poland)] were incubated at room temperature (22 ± 2 °C) for 10 minutes. Optical density 202 of solution was measured at 540/650 nm using Microplate Reader (Behringer, Germany). 203 The nitrite concentration (M) was calculated from the prepared standard curve for the 204 known NaNO 2 concentrations. RPMI medium with 10% FCS in 96-well plates. Phorbol-myristate-acetate (20.0 ng/mL) 261 and ionomycin (500.0 ng/mL) (Merck, Austria) were added to the wells after five days. 262 Cells were incubated for an additional 8 h and then harvested, and cell-free supernatants 263 were collected after centrifugation and stored at -20 °C for the subsequent determination 264 of the studied cytokine levels. Fig. 2A ). Comparing with a control, GC extract had no effect on adhesive capacity of 291 PMA-stimulated PMs, while GA extract (in all tested concentrations) enhanced this 292 ability (Fig. 2B) . 293 GC and GA extracts showed no significant effect on phagocytic function of non-294 stimulated PMs (data not shown). However, in the case of LPS-stimulated PMs, GA 295 extract (in all tested concentrations) statistically considerable up-regulated this activity in 296 comparison with non-treated PMs and PMs treated with GC extract (Fig. 3) .
298
Effect of Ganoderma lucidum extracts on ROS and NO production by PMs 299
The treatment of non-stimulated PMs with GC and GA extracts no affected their 300 potential of ROS production (data not shown). Comparing with adequate control cells, 301 GC extract had no effect on ROS production by LPS-stimulated PMs, contrary to GA 302 extract which statistically significant increased this ability (Fig. 4) . 303 Treatment of non-stimulated and LPS-stimulated PMs with GC and GA extracts, in all 304 tested concentrations (except treatment of non-stimulated cells with 100.0 µg/mL of GC 305 extract) caused increase of NO production. Furthermore, GA extract was statistically 306 stronger inducer of NO production by tested PMs than GC extract (Fig. 5 ). 313 Additionally, thus simultaneous treatment of TLR 3 and TLR 7-stimulated MoDCs with 314 GA extract also affected the expression of co-stimulatory molecules, CD86 and CD40, as 315 well as chemokine receptor, CCR7 (Fig. 6A) . 316 The additions of GC extract stimulated production of IL-6 and TNF-α, had no effect 317 on production of IL-12, and inhibited the production of IL-10 by TLR3 and 7-stimulated 318 MoDCs. On the other hand, GA extract inhibited the production of IL-6 and IL-10 and 319 12 had no effect on TNF-α and IL-12 production by studied MoDCs compared to MoDC 320 treated only with TLR3 and TLR7 antagonist (Fig. 6B ). substrate. This is the first report on it and our findings showed that crude extract of G. . Therefore, down-regulation of IL-10 production 462 may serve as an additional mechanism for promotion of the Th1 immune response. 463 Bearing in mind the significance of anti-tumor vaccines, this study performed to find 464 optimal protocol for development of DCs able to induce adequate immune response. The 465 results that we obtained in this study suggest that simultaneous TLR3 and TLR7 signaling 
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Effect of Ganoderma lucidum extracts on phenotype and cytokine production by MoDCs
